News for Your Practice

Noninvasive test identifies more than 98% of Down syndrome cases

Author and Disclosure Information

 

References

The ISPD recommends that the following information be conveyed to the patient:

  • The test identifies only Down syndrome, or only “about half of the fetal aneuploidy that would be identified through amniocentesis or CVS”.
  • The test is not perfect; that is, it does not identify all cases of fetal Down syndrome.
  • Because false-positive results are possible, women who test positive still need the result confirmed by amniocentesis or CVS.
  • If a woman tests positive for Down syndrome on the MPS test, the waiting period for the results of confirmatory testing may be “highly stressful”.
  • The MPS test may not be informative in all cases.
  • Women who have an elevated risk of having a child with a “prenatally diagnosable disorder with Mendelian pattern of inheritance, microdeletion syndrome, or some other conditions” still need to undergo amniocentesis or CVS.3

We want to hear from you! Tell us what you think.

Pages

Recommended Reading

Pelvic Floor Disorders Higher After Vaginal Delivery vs. C-Section
MDedge ObGyn
Anesthetic Agents
MDedge ObGyn
Simulator Teaches Force Modulation for Shoulder Dystocia
MDedge ObGyn
Pregnancy Outcomes Not Marred by H1N1 Flu
MDedge ObGyn
Itchy and Pregnant? Consider Range of Causes
MDedge ObGyn
Maternal Smoking May Increase Future CVD in Children
MDedge ObGyn
Pregnancy Weight Gain: Why the Disconnect?
MDedge ObGyn
Influenza Vaccine in Pregnancy Seems to Benefit Baby, Too
MDedge ObGyn
Gestational Diabetes Therapies and Fetal Risk
MDedge ObGyn
Pelvic Floor Disorders Higher After Vaginal Delivery vs. C-Section
MDedge ObGyn